Skip to main content

Assessment of BRCA1 and BRCA2 Germline Variant Data From Patients With Breast Cancer in a Real-World Data Registry.

Publication ,  Journal Article
Nepomuceno, TC; Lyra, P; Zhu, J; Yi, F; Martin, RH; Lupu, D; Peterson, L; Peres, LC; Berry, A; Iversen, ES; Couch, FJ; Mo, Q; Monteiro, AN
Published in: JCO clinical cancer informatics
May 2024

The emergence of large real-world clinical databases and tools to mine electronic medical records has allowed for an unprecedented look at large data sets with clinical and epidemiologic correlates. In clinical cancer genetics, real-world databases allow for the investigation of prevalence and effectiveness of prevention strategies and targeted treatments and for the identification of barriers to better outcomes. However, real-world data sets have inherent biases and problems (eg, selection bias, incomplete data, measurement error) that may hamper adequate analysis and affect statistical power.Here, we leverage a real-world clinical data set from a large health network for patients with breast cancer tested for variants in BRCA1 and BRCA2 (N = 12,423). We conducted data cleaning and harmonization, cross-referenced with publicly available databases, performed variant reassessment and functional assays, and used functional data to inform a variant's clinical significance applying American College of Medical Geneticists and the Association of Molecular Pathology guidelines.In the cohort, White and Black patients were over-represented, whereas non-White Hispanic and Asian patients were under-represented. Incorrect or missing variant designations were the most significant contributor to data loss. While manual curation corrected many incorrect designations, a sizable fraction of patient carriers remained with incorrect or missing variant designations. Despite the large number of patients with clinical significance not reported, original reported clinical significance assessments were accurate. Reassessment of variants in which clinical significance was not reported led to a marked improvement in data quality.We identify the most common issues with BRCA1 and BRCA2 testing data entry and suggest approaches to minimize data loss and keep interpretation of clinical significance of variants up to date.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JCO clinical cancer informatics

DOI

EISSN

2473-4276

ISSN

2473-4276

Publication Date

May 2024

Volume

8

Start / End Page

e2300251

Related Subject Headings

  • Registries
  • Middle Aged
  • Humans
  • Germ-Line Mutation
  • Genetic Predisposition to Disease
  • Female
  • Electronic Health Records
  • Breast Neoplasms
  • BRCA2 Protein
  • BRCA1 Protein
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Nepomuceno, T. C., Lyra, P., Zhu, J., Yi, F., Martin, R. H., Lupu, D., … Monteiro, A. N. (2024). Assessment of BRCA1 and BRCA2 Germline Variant Data From Patients With Breast Cancer in a Real-World Data Registry. JCO Clinical Cancer Informatics, 8, e2300251. https://doi.org/10.1200/cci.23.00251
Nepomuceno, Thales C., Paulo Lyra, Jianbin Zhu, Fanchao Yi, Rachael H. Martin, Daniel Lupu, Luke Peterson, et al. “Assessment of BRCA1 and BRCA2 Germline Variant Data From Patients With Breast Cancer in a Real-World Data Registry.JCO Clinical Cancer Informatics 8 (May 2024): e2300251. https://doi.org/10.1200/cci.23.00251.
Nepomuceno TC, Lyra P, Zhu J, Yi F, Martin RH, Lupu D, et al. Assessment of BRCA1 and BRCA2 Germline Variant Data From Patients With Breast Cancer in a Real-World Data Registry. JCO clinical cancer informatics. 2024 May;8:e2300251.
Nepomuceno, Thales C., et al. “Assessment of BRCA1 and BRCA2 Germline Variant Data From Patients With Breast Cancer in a Real-World Data Registry.JCO Clinical Cancer Informatics, vol. 8, May 2024, p. e2300251. Epmc, doi:10.1200/cci.23.00251.
Nepomuceno TC, Lyra P, Zhu J, Yi F, Martin RH, Lupu D, Peterson L, Peres LC, Berry A, Iversen ES, Couch FJ, Mo Q, Monteiro AN. Assessment of BRCA1 and BRCA2 Germline Variant Data From Patients With Breast Cancer in a Real-World Data Registry. JCO clinical cancer informatics. 2024 May;8:e2300251.

Published In

JCO clinical cancer informatics

DOI

EISSN

2473-4276

ISSN

2473-4276

Publication Date

May 2024

Volume

8

Start / End Page

e2300251

Related Subject Headings

  • Registries
  • Middle Aged
  • Humans
  • Germ-Line Mutation
  • Genetic Predisposition to Disease
  • Female
  • Electronic Health Records
  • Breast Neoplasms
  • BRCA2 Protein
  • BRCA1 Protein